Furthermore, MYC activation exerts dual immunosuppressive effects by downregulating JAK2 expression, thereby attenuating both type I and type II IFN signaling cascades and diminishing tumor cell responsiveness to interferon stimulation (123). Here, IFNA1 is linked to neoplasm.